RadioStereometric Analysis of the Plus orthopedics SL-MIA stem and the SL-stem, a randomised controlled trial. - RSA of the SL-MIA Plus and SL-Plus stem, a RCT

Deventer Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•Patients with primary osteoarthritis of the hip with an indication for total hip arthroplasty.
•Age 50 to 80
•ASA 1 and 2
•unilateral coxartrhosis
•Informed consent of patient
•Initial willingness to comply with the post-operative review program

•Ability to comply to the postoperative investigational program
•THA or osteosynthesis on the contra lateral hip (not suitable as reference during DEXA-scan)
•Expectation that the contra lateral hip also needs a THA within a year
•THA because of fracture
•Prior surgery on effected hip
•Revision arthroplasty
•Acute or chronic infections (local or systemic)
•Metabolic diseases of the bone
•Diseases of the muscular, nervous, or vascular systems that seriously will involve the mobility of the patient after a THA
•Femora with structural defects or poor bone quality affecting the stability of the prosthesis
•Any concomitant disease which may endanger the implant*s function
•Patients with rheumatic, renal, hepatic or gastrointestinal disease and patients using medication that interferes with mineral metabolism (i.e. treatment for osteoporosis or long-term steroid therapy).

发起方